Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
Authors
Keywords
Head and neck cancer, Cisplatin resistance, Wogonin, Reactive oxygen species, Cell death
Journal
APOPTOSIS
Volume 21, Issue 11, Pages 1265-1278
Publisher
Springer Nature
Online
2016-08-20
DOI
10.1007/s10495-016-1284-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor Regression Patterns Based on Follow-up Duration in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy
- (2015) Moonkyoo Kong et al. Clinical and Experimental Otorhinolaryngology
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells
- (2014) C. Qian et al. FREE RADICAL RESEARCH
- Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: A systematic review and meta-analysis of published studies
- (2014) Fausto Petrelli et al. ORAL ONCOLOGY
- p53 regulates a non-apoptotic death induced by ROS
- (2013) J Montero et al. CELL DEATH AND DIFFERENTIATION
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical Significance of Keap1 and Nrf2 in Oral Squamous Cell Carcinoma
- (2013) Cong-Fa Huang et al. PLoS One
- Roles of Keap1-Nrf2 System in Upper Aerodigestive Tract Carcinogenesis
- (2012) A. Ohkoshi et al. Cancer Prevention Research
- Wogonin Induces Reactive Oxygen Species Production and Cell Apoptosis in Human Glioma Cancer Cells
- (2012) Cheng-Fang Tsai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of Nrf2 Is Required for Up-Regulation of the π Class of Glutathione S-Transferase in Rat Primary Hepatocytes with l-Methionine Starvation
- (2012) Ai-Hsuan Lin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response
- (2012) Yan Zhong et al. MOLECULAR CARCINOGENESIS
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
- (2010) John D. Hayes et al. ANTIOXIDANTS & REDOX SIGNALING
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
- (2010) T. Jiang et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features
- (2010) L. M. Solis et al. CLINICAL CANCER RESEARCH
- Sulforaphane and α-Lipoic Acid Upregulate the Expression of the π Class of Glutathione S-Transferase through c-Jun and Nrf2 Activation
- (2010) Chong-Kuei Lii et al. JOURNAL OF NUTRITION
- Inhibition of P-Glycoprotein by Wogonin Is Involved with the Potentiation of Etoposide-Induced Apoptosis in Cancer Cells
- (2009) Eibai Lee et al. Annals of the New York Academy of Sciences
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
- (2009) S. Homma et al. CLINICAL CANCER RESEARCH
- Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
- (2009) Yoo Ri Kim et al. JOURNAL OF PATHOLOGY
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents
- (2009) Larry G. Higgins et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
- (2008) Min Li-Weber CANCER TREATMENT REVIEWS
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Recent Advances in Head and Neck Cancer
- (2008) Robert I. Haddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mitochondria in cancer cells: what is so special about them?
- (2008) Vladimir Gogvadze et al. TRENDS IN CELL BIOLOGY
- Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to cancer cell resistance
- (2007) Jeong-Min Cho et al. CANCER LETTERS
- Differential apoptotic effect of wogonin and nor-wogonin via stimulation of ROS production in human leukemia cells
- (2007) Jyh-Ming Chow et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started